Cimiracemoside C
CAS No. 256925-92-5
Cimiracemoside C ( Cimicifugoside M )
Catalog No. M24157 CAS No. 256925-92-5
Cimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 149 | In Stock |
|
10MG | 255 | In Stock |
|
25MG | 430 | In Stock |
|
50MG | 618 | In Stock |
|
100MG | 861 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCimiracemoside C
-
NoteResearch use only, not for human use.
-
Brief DescriptionCimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
-
DescriptionCimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
-
SynonymsCimicifugoside M
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorAMPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number256925-92-5
-
Formula Weight620.8
-
Molecular FormulaC35H56O9
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@]12[C@@]3([H])[C@@]4(CC[C@@]1([C@]5([H])C(O[C@H](C(C)(O)C)[C@@]6([H])C[C@H]5C)(O6)[C@@H]2O)C)[C@@]7([C@@](C(C)([C@@H](O[C@@]8([H])[C@@H]([C@H]([C@@H](O)CO8)O)O)CC7)C)([H])CC3)C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice.Phytomedicine. 2014 Sep 25;21(11):1382-9.
molnova catalog
related products
-
7-Methoxyisoflavone
7-Methoxyisoflavone is an activator of adenosine monophosphate-activated protein kinase (AMPK).
-
A-769662
A small molecule AMPK activator that directly stimulates partially purified rat liver AMPK (EC50=0.8 uM) and inhibits fatty acid synthesis in primary rat hepatocytes (IC50=3.2 uM).
-
GSK621
GSK621 (GSK-621) is a potent, specific AMPK agonist (activator), induces cytotoxicity in AML (IC50=13-30 uM).